Polymorphic N-acetylation of a caffeine metabolite.
In the course of investigations into variability in the metabolism of caffeine in human populations, urinary levels of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), a newly discovered ring-opened metabolite of caffeine, were found to be both bimodally distributed and interethnically variable in samples (Caucasian: n = 42; Oriental: n = 26) from the Toronto population. To test the premise that the polymorphic N-acetyltransferase enzyme (E.C.2.3.1.5) could be responsible for the production of AFMU, 20 of the subjects were phenotyped for acetylator status using sulfamethazine (SMZ). Concordance for all subjects between AFMU production and SMZ acetylation strongly suggests that the acetylation polymorphism is involved in the formation of AFMU in man.
D000107:Acetylation; D000123:Acetyltransferases / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D044466:Asian People; D002110:Caffeine / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011110:Polymorphism, Genetic; D013418:Sulfamethazine / Q000378:metabolism; D014498:Uracil / Q000031:analogs & derivatives* / Q000652:urine; D044465:White People
D002110:Caffeine; D013418:Sulfamethazine; D014498:Uracil; C036692:5-acetylamino-6-formylamino-3-methyluracil; D000123:Acetyltransferases